US moots curbs on funds to Chinese biotech firms

The administration of US President Donald Trump is seeking to restrict investment in Chinese biotechnology companies, potentially complicating financial ties at a time when US drugmakers are increasingly turning to China for new medicines.The US Department of the Treasury on Thursday proposed adding